MAFLD: Renovation of clinical practice and disease awareness of fatty liver

被引：80
作者：
Kawaguchi, Takumi [1 ]
Tsutsumi, Tsubasa [1 ]
Nakano, Dan [1 ]
Torimura, Takuji [1 ]
机构：
[1] Kurume Univ, Dept Med, Div Gastroenterol, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan
来源：
HEPATOLOGY RESEARCH | 2022年 / 52卷 / 05期
关键词：
atherosclerotic cardiovascular disease; disease awareness; hepatic fibrosis; metabolic-associated fatty liver; steatosis; NONALCOHOLIC STEATOHEPATITIS; JAPANESE PATIENTS; HEPATOCELLULAR-CARCINOMA; RS738409; POLYMORPHISM; AMERICAN ASSOCIATION; METABOLIC SYNDROME; FIBROSIS; PNPLA3; SEVERITY; OUTCOMES;
D O I：
10.1111/hepr.13706
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Recently, international expert panels have proposed a new definition of fatty liver: metabolic dysfunction-associated fatty liver disease (MAFLD). MAFLD is not just a simple renaming of non-alcoholic fatty liver disease (NAFLD). The unique feature of MAFLD is the inclusion of metabolic dysfunctions, which are high-risk factors for events. In addition, MAFLD is independent of alcohol intake and the co-existing causes of liver disease. This new concept of MAFLD may have a widespread impact on patients, medical doctors, medical staff, and various stakeholders regarding fatty liver. Thus, MAFLD may renovate clinical practice and disease awareness of fatty liver. In this review, we introduce the definition of and rationale for MAFLD. We further describe representative cases showing how the diagnostic processes differ between MAFLD and NAFLD. We also summarize recent studies comparing MAFLD with NAFLD and discuss the impact of MAFLD on clinical trials, Japanese populations, and disease awareness.
引用
收藏
页码：422 / 432
页数：11
相关论文
共 94 条
[1]   Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan [J].
Akuta, Norio ;
Kawamura, Yusuke ;
Arase, Yasuji ;
Suzuki, Fumitaka ;
Sezaki, Hitomi ;
Hosaka, Tetsuya ;
Kobayashi, Masahiro ;
Kobayashi, Mariko ;
Saitoh, Satoshi ;
Suzuki, Yoshiyuki ;
Ikeda, Kenji ;
Kumada, Hiromitsu .
GUT AND LIVER, 2016, 10 (03) :437-445
[2]   Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease [J].
Angulo, Paul ;
Kleiner, David E. ;
Dam-Larsen, Sanne ;
Adams, Leon A. ;
Bjornsson, Einar S. ;
Charatcharoenwitthaya, Phunchai ;
Mills, Peter R. ;
Keach, Jill C. ;
Lafferty, Heather D. ;
Stahler, Alisha ;
Haflidadottir, Svanhildur ;
Bendtsen, Flemming .
GASTROENTEROLOGY, 2015, 149 (02) :389-+
[3]   Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus [J].
Blomdahl, Julia ;
Nasr, Patrik ;
Ekstedt, Mattias ;
Kechagias, Stergios .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 115
[4]   Alcohol Use in Patients with Chronic Liver Disease [J].
Caputo, Fabio ;
Zoli, Giorgio ;
Bernardi, Mauro .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (26) :2577-2578
[5]   The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Diehl, Anna Mae ;
Brunt, Elizabeth M. ;
Cusi, Kenneth ;
Charlton, Michael ;
Sanyal, Arun J. .
GASTROENTEROLOGY, 2012, 142 (07) :1592-1609
[6]   Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study [J].
Chang, Yoosoo ;
Cho, Yong Kyun ;
Kim, Yejin ;
Sung, Eunju ;
Ahn, Jiin ;
Jung, Hyun-Suk ;
Yun, Kyung Eun ;
Shin, Hocheol ;
Ryu, Seungho .
HEPATOLOGY, 2019, 69 (01) :64-75
[7]   Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B [J].
Choi, Hannah S. J. ;
Brouwer, Willem P. ;
Zanjir, Wayel M. R. ;
de Man, Robert A. ;
Feld, Jordan J. ;
Hansen, Bettina E. ;
Janssen, Harry L. A. ;
Patel, Keyur .
HEPATOLOGY, 2020, 71 (02) :539-548
[8]   Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population [J].
Ciardullo, Stefano ;
Perseghin, Gianluca .
LIVER INTERNATIONAL, 2021, 41 (06) :1290-1293
[9]   Lack of awareness of liver organ damage in patients with type 2 diabetes [J].
Ciardullo, Stefano ;
Monti, Tommaso ;
Perseghin, Gianluca .
ACTA DIABETOLOGICA, 2021, 58 (05) :651-655
[10]   From NAFLD to MAFLD: Nurse and allied health perspective [J].
Clayton, Michelle ;
Fabrellas, Nuria ;
Luo, Jinkai ;
Alghamdi, Mohammed G. ;
Hafez, Azaa ;
Al Qadiri, Tahani ;
Owise, Nevin ;
Attia, Dina .
LIVER INTERNATIONAL, 2021, 41 (04) :683-691
12345678910